- Citations, last 5 years
- 315
- Works, last 5 years
- 62
- h-index
- 170
- Scientists listed
- 6
- Grants since 2016
- 9
Grants received
2024–2025 · research · R43
Fibrinogen-coated albumin nanospheres for mitigation of irradiation-induced wound healing impairment in breast cancer patients.
Richard Yen · FibroGen (United States) · funded by National Institutes of Health
2021–2022 · research · R43
A novel agent to manage thrombocytopenic patients with platelet transfusion refractoriness
Richard Yen · FibroGen (United States) · funded by National Institutes of Health
2021–2023 · research · R43
Fibrinogen coated albumin spheres to accelerate bone healing in older adults.
Richard Yen · FibroGen (United States) · funded by National Institutes of Health
2021–2022 · grant · Standard Grant
SBIR Phase I: Quieting systemic hyper-inflammation (COVID-19)
Kendell Pawelec · FibroGen (United States) · funded by National Science Foundation
2020–2021 · research · R43
Demonstrating the feasibility of CCG-257081 as a preventive therapy to inhibit bleomycin-induced lung fibrosis in mice
Kendell Marleen Pawelec · FibroGen (United States) · funded by National Institutes of Health
2019–2023 · research · R44
A multivalent, easy-to-use product to mitigate and treat radiation exposure
Richard Yen · FibroGen (United States) · funded by National Institutes of Health
2019 · research · R43
A multivalent, easy-to-use product to mitigate and treat radiation exposure
Richard Yen · FibroGen (United States) · funded by National Institutes of Health
2019–2022 · research · R44
A multivalent, easy-to-use product to mitigate and treat radiation exposure
Richard Yen · FibroGen (United States) · funded by National Institutes of Health
2018–2021 · research · R43
Demonstrating the feasibility of CCG-257081 as a preventive therapy to inhibit bleomycin-induced lung fibrosis in mice
Kendell Marleen Pawelec · FibroGen (United States) · funded by National Institutes of Health